[1] Bastianelli C, Farris M, Rapiti S,et al. Different bleeding patterns with the use of levonorgestrel intrauterine system: are they associated with changes in uterine artery blood flow? [J].Biomed Res Int, 2014,2014(2): 815127. [2] 程莉.释放孕激素的宫内节育器——曼月乐[J]. 中国计划生育学杂志, 2012,20(12):857-858. [3] 李瑛,王兰明,张世琨. 避孕药具不良事件监测与防治[M].北京人民卫生出版社,2007:77-78. [4] 张磊,张妍,车焱,等. 曼月乐与不同铜表面积宫内节育器比较的系统评估[J]. 中国计划生育学杂志, 2011,19(12):719-724. [5] Goodman S, Hendlish S K, Reeves M F, et al. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion[J]. Contraception, 2008, 78(2):143-148. [6] Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion[J]. Contraception,2008, 78(2):149-154. [7] 殷明红,王海云,陈翠琴,等. 月经后或人流术后放置曼月乐对 月经的影响[J].同济大学学报:医学版, 2009, 30(6):87-90. [8] Herman M C, van den Brink M J, Geomini M, et al.Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial[J]. BMC Womens Health, 2013,13(31):32-36. [9] Heikinheimo O, Inki P, Schmelter T, et al.Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study[J]. Hum Reprod, 2014,29(6):1182-1188. [10] 陈蓉. 曼月乐用于子宫腺肌病及功能失调性子宫出血73例[J].中国药业, 2015,24(13):115-117. [11] Depypere H, Inki P. The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review[J]. Climacteric, 2015,18(4):470-482. [12] 孙亚坤. 左炔诺孕酮宫内节育系统(曼月乐)满意和咨询情况及其相关研究[D].中国协和医科大学(北京协和医学院),2008:21-30. [13] 孙亚坤,程怡民,李汀. 曼月乐满意度及其影响因素分析[J].中国妇幼保健, 2008,23(14):1966-1968. [14] 唐岚,朱金媛. 知情同意书在放置曼月乐时的应用与体会[J].实用医技杂志, 2007,14(24):3294-3295. [15] Backman T, Huhtala S, Luoto R,et al.Advance information improves user satisfaction with the levonorgestrel intrauterine system[J]. Obstet Gynecol, 2002,99(4):608-613. |